You are currently viewing a new version of our website. To view the old version click .
Journal: CancersVolume: 14Number: 2934
Article: Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
  • Authors:
  • Colin D. Godwin1,2,
  • Eduardo Rodríguez-Arbolí1 and
  • Megan Othus3
  • et al.
Link: https://www.mdpi.com/2072-6694/14/12/2934

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.